19 min

Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors Medicine Matters rheumatology

    • Medicine

Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

  • Springer Healthcare, part of the Springer Nature group

Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

19 min

  • Springer Healthcare, part of the Springer Nature group